Benzinga
18 Aug 2026, 12:45 UTC · 1w ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Analysis by Kasper Rasmussen · Founder & analyst
What the story claims
1 claim · each scored for market impact
A Wall Street analyst has initiated coverage of Definium Therapeutics (DFTX) with a bullish outlook. — Bullish analyst initiations typically create positive short-term price pressure and increase investor visibility for small-cap stocks.
+0.30Which stocks this story touches
A Wall Street analyst began coverage of the company on a bullish note.
Continue reading
6 related stories
Search tags
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Seeking Alpha
17h ago
